15 May 2017

Patheon to be acquired by Thermo Fisher Scientific in a USD 7.2 billion recommended tender offer

Thermo Fisher Scientific will commence a tender offer to acquire all of the issued and outstanding shares of Patheon for USD 35.00 per share in cash. The transaction represents a purchase price of approximately USD 7.2 billion, which includes the assumption of approximately USD 2.0 billion of net debt.

Team: Paul Cronheim, Tijmen Klein Bronsvoort and Rick van ‘t Wout.

We keep track of you on our site with cookies, in order to offer the basic functionality of the website and generate user statistics on an anonymous basis to make our website more user-friendly. We do not use or share your data with third parties for advertising purposes.
Accept cookiesChange cookiesClick here for more information about our cookies.